Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR23206-296] to IL-13 receptor alpha 1 - BSA and Azide free
  • Suitable for: Flow Cyt
  • Reacts with: Human

Overview

  • Product name

    Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free
    See all IL-13 receptor alpha 1 primary antibodies

  • Description

    Rabbit monoclonal [EPR23206-296] to IL-13 receptor alpha 1 - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    See all applications and species data

  • Immunogen

    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • Flow cyt: HDLM-2 and PANC-1 cells.

  • General notes

    ab277485 is the carrier-free version of ab246519. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with

    ab277485 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Flow Cytometry - Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)
    Flow Cytometry - Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)

    This data was developed using ab246519, the same antibody clone in a different buffer formulation.

    Flow cytometric analysis of Jurkat (Human T cell leukemia T lymphocyte, Left)/ HDLM-2 (Human Hodgkin lymphoma, Right) cells labelling IL-13 receptor alpha 1 with ab246519 at 1/50 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody. Negative control: Jurkat (PMID: 15163701). Gated on viable cells.

  • Flow Cytometry - Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)
    Flow Cytometry - Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)

    This data was developed using ab246519, the same antibody clone in a different buffer formulation.

    Flow cytometric analysis of Ramos (Human Burkitt's lymphoma B lymphocyte, Left)/ PANC-1 (Human pancreatic epithelioid carcinoma epithelial cell, Right) cells labelling IL-13 receptor alpha 1 with ab246519 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 647, ab150079) at 1/2000 dilution was used as the secondary antibody. Negative control: Ramos. Gated on viable cells.

  • Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)
    Anti-IL-13 receptor alpha 1 antibody [EPR23206-296] - BSA and Azide free (ab277485)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.